1-3 of 3
Jeremy A. Ryan, SM
Close
Sort by
Journal Articles

A Phase 1 Dose-Escalation Study of Adding Venetoclax to a Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic Hematopoietic Cell Transplantation for Patients with High Risk Myeloid Malignancies

Jacqueline S Garcia, MD, Haesook T. Kim, PhD, Jennifer Brock, Amy Han, MPH, Jeremy A. Ryan, SM, Thelma Mashaka, BA, Anthony G. Letai, MD PhD, R. Coleman Lindsley, MD PhD, Mahasweta Gooptu, MD, Vincent T. Ho, MD, John Koreth, MBBS, DPhil, Sarah Nikiforow, MD PhD, Rizwan Romee, MD PhD, Ilene Galinsky, Martha Wadleigh, MD, David P. Steensma, MD, Richard M. Stone, MD, Robert J. Soiffer, MD, Corey Cutler, MD MPH, FRCPC, Daniel J. DeAngelo, MD, Joseph H. Antin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 258.
https://doi.org/10.1182/blood-2019-126172
Published: 2019
Journal Articles

Targeted Inhibition of PI3K α/δ Is Synergistic with BCL-2 Blockade in Genetically Defined Subtypes of DLBCL

Kamil Bojarczuk, PhD, Kirsty Wienand, PhD, Jeremy A. Ryan, SM, Linfeng Chen, PhD, Mariana Villalobos-Ortiz, Elisa Mandato, PhD, Joanna Stachura, MSc, Lee N. Lawton, PhD, Anthony Letai, MD PhD, Bjoern Chapuy, MDPhD, Margaret A. Shipp, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 39.
https://doi.org/10.1182/blood-2018-99-113647
Published: 2018
Journal Articles

Apoptotic Blocks in Primary Non-Hodgkin B-Cell Lymphomas Identified By BH3 Profiling

Nathalie A Johnson, MD PhD, Claudia M Wever, PhD, Dominique Geoffrion, BSc, Ghassemian Artin, MD, Brailovski Eugene, Pierre Sesques, MD, Jeremy A. Ryan, SM, Liliana Stoica, Josee Hebert, MD, Tina Petrogiannis-Haliotis, MD PhD, Svetlana Dmitrienko, MD PhD, Frenkiel Saul, MD, German Ott, MD, Annette Staiger, Christian Steidl, MD, David W. Scott, PhD MD, FRACP, FRCPA, Koren Kathleen Mann, PhD, Anthony Letai, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4126.
https://doi.org/10.1182/blood-2018-99-118225
Published: 2018